BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 15978256)

  • 1. Troglitazone reverses the inhibition of nitric oxide production by high glucose in cultured bovine retinal pericytes.
    Kim J; Oh YS; Shinn SH
    Exp Eye Res; 2005 Jul; 81(1):65-70. PubMed ID: 15978256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Troglitazone inhibits synthesis of transforming growth factor-beta1 and reduces matrix production in human peritoneal mesothelial cells.
    Peng Y; Liu H; Liu F; Liu Y; Li J; Chen X
    Nephrology (Carlton); 2006 Dec; 11(6):516-23. PubMed ID: 17199790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxic role of methylglyoxal in rat retinal pericytes: Involvement of a nuclear factor-kappaB and inducible nitric oxide synthase pathway.
    Kim J; Kim OS; Kim CS; Kim NH; Kim JS
    Chem Biol Interact; 2010 Oct; 188(1):86-93. PubMed ID: 20621070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The thiazolidinedione drug troglitazone up-regulates nitric oxide synthase expression in vascular endothelial cells.
    Goya K; Sumitani S; Otsuki M; Xu X; Yamamoto H; Kurebayashi S; Saito H; Kouhara H; Kasayama S
    J Diabetes Complications; 2006; 20(5):336-42. PubMed ID: 16949522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of sodium-dependent glucose uptake by captopril improves high-glucose-induced morphological and functional changes of cultured bovine retinal pericytes.
    Wakisaka M; Yoshinari M; Nakamura S; Asano T; Sonoki K; Shi Ah; Iwase M; Takata Y; Fujishima M
    Microvasc Res; 1999 Nov; 58(3):215-23. PubMed ID: 10527765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Changes of reactive oxygen species in mitochondria of retinal endothelial cells and pericytes induced by high glucose].
    Cui Y; Xu X; Bi HS
    Zhonghua Yan Ke Za Zhi; 2006 Feb; 42(2):131-8. PubMed ID: 16643728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High glucose inhibits expression of inducible and constitutive nitric oxide synthase in bovine aortic endothelial cells.
    Guo X; Chen LW; Liu WL; Guo ZG
    Acta Pharmacol Sin; 2000 Apr; 21(4):325-8. PubMed ID: 11324460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Keratinocyte-derived vascular endothelial growth factor biosynthesis represents a pleiotropic side effect of peroxisome proliferator-activated receptor-gamma agonist troglitazone but not rosiglitazone and involves activation of p38 mitogen-activated protein kinase: implications for diabetes-impaired skin repair.
    Schiefelbein D; Seitz O; Goren I; Dissmann JP; Schmidt H; Bachmann M; Sader R; Geisslinger G; Pfeilschifter J; Frank S
    Mol Pharmacol; 2008 Oct; 74(4):952-63. PubMed ID: 18599600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Troglitazone up-regulates vascular endothelial argininosuccinate synthase.
    Goodwin BL; Corbin KD; Pendleton LC; Levy MM; Solomonson LP; Eichler DC
    Biochem Biophys Res Commun; 2008 May; 370(2):254-8. PubMed ID: 18375203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide production and regulation of endothelial nitric-oxide synthase phosphorylation by prolonged treatment with troglitazone: evidence for involvement of peroxisome proliferator-activated receptor (PPAR) gamma-dependent and PPARgamma-independent signaling pathways.
    Cho DH; Choi YJ; Jo SA; Jo I
    J Biol Chem; 2004 Jan; 279(4):2499-506. PubMed ID: 14593122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinal pericytes control expression of nitric oxide synthase and endothelin-1 in microvascular endothelial cells.
    Martin AR; Bailie JR; Robson T; McKeown SR; Al-Assar O; McFarland A; Hirst DG
    Microvasc Res; 2000 Jan; 59(1):131-9. PubMed ID: 10625580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thiamine and benfotiamine prevent increased apoptosis in endothelial cells and pericytes cultured in high glucose.
    Beltramo E; Berrone E; Buttiglieri S; Porta M
    Diabetes Metab Res Rev; 2004; 20(4):330-6. PubMed ID: 15250036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Troglitazone directly inhibits CO(2) production from glucose and palmitate in isolated rat skeletal muscle.
    Fürnsinn C; Brunmair B; Neschen S; Roden M; Waldhäusl W
    J Pharmacol Exp Ther; 2000 May; 293(2):487-93. PubMed ID: 10773019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-associated proteoglycans of retinal pericytes and endothelial cells: modulation by glucose and ascorbic acid.
    Fisher EJ; McLennan SV; Yue DK; Turtle JR
    Microvasc Res; 1994 Sep; 48(2):179-89. PubMed ID: 7854204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth regulation of bovine retinal pericytes by transforming growth factor-beta2 and plasmin.
    Katsura MK; Mishima HK; Minamoto A; Ishibashi F; Yamashita H
    Curr Eye Res; 2000 Mar; 20(3):166-72. PubMed ID: 10694890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sympathetic neurotransmission modulates expression of inflammatory markers in the rat retina.
    Steinle JJ
    Exp Eye Res; 2007 Jan; 84(1):118-25. PubMed ID: 17067575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor up-regulates the expression of intracellular adhesion molecule-1 in retinal endothelial cells via reactive oxygen species, but not nitric oxide.
    Zhang XL; Wen L; Chen YJ; Zhu Y
    Chin Med J (Engl); 2009 Feb; 122(3):338-43. PubMed ID: 19236815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Troglitazone inhibits tumor growth in hepatocellular carcinoma in vitro and in vivo.
    Yu J; Qiao L; Zimmermann L; Ebert MP; Zhang H; Lin W; Röcken C; Malfertheiner P; Farrell GC
    Hepatology; 2006 Jan; 43(1):134-43. PubMed ID: 16374840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of troglitazone on tumor necrosis factor alpha and transforming growth factor beta expression and action in human adipocyte precursor cells in primary culture.
    Skurk T; Birgel M; Lee YM; Hauner H
    Metabolism; 2006 Mar; 55(3):309-16. PubMed ID: 16483873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-3 agonist-induced lipolysis and nitric oxide production: relationship to PPARgamma agonist/antagonist and AMP kinase modulation.
    Hodis J; Vaclavíková R; Farghali H
    Gen Physiol Biophys; 2011 Mar; 30(1):90-9. PubMed ID: 21460417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.